.Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G04B_Urologicals.G04BX17_SodiumSalicylateAndMethe.SodiumSalicylateAndMethe .Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G04B_Urologicals.G04BX17_SodiumSalicylateAndMethe.SodiumSalicylateAndMethe| name: | SodiumSalicylateAndMethenamine | |
| ATC code: | G04BX17 | |
| route: | oral | |
| compartments: | 1 | |
| dosage: | 1000 | mg |
| volume of distribution: | 0.2 | L |
| clearance: | 2.5 | L/h |
| other parameters in model implementation | ||
Sodium salicylate and methenamine is a combination drug formerly used for the treatment of urinary tract infections (UTIs). Methenamine acts as a urinary antiseptic by releasing formaldehyde in acidic urine, while sodium salicylate was used for its analgesic and anti-inflammatory effects. This combination is largely obsolete and is not commonly used or approved for UTI treatment today due to more effective and safer alternatives.
Estimated pharmacokinetic parameters for an adult oral dose in absence of direct published PK models for the combination product.